fosamprenavir has been researched along with miglustat in 1 studies
| Studies (fosamprenavir) | Trials (fosamprenavir) | Recent Studies (post-2010) (fosamprenavir) | Studies (miglustat) | Trials (miglustat) | Recent Studies (post-2010) (miglustat) |
|---|---|---|---|---|---|
| 174 | 55 | 37 | 383 | 28 | 185 |
| Protein | Taxonomy | fosamprenavir (IC50) | miglustat (IC50) |
|---|---|---|---|
| Sucrase-isomaltase | Mus musculus (house mouse) | 1.05 | |
| Maltase-glucoamylase, intestinal | Homo sapiens (human) | 5.55 | |
| Lysosomal acid glucosylceramidase | Homo sapiens (human) | 5 | |
| Lysosomal alpha-glucosidase | Homo sapiens (human) | 0.1 | |
| Sucrase-isomaltase, intestinal | Homo sapiens (human) | 0.5 | |
| Sucrase-isomaltase, intestinal | Rattus norvegicus (Norway rat) | 2.156 | |
| Protein-lysine 6-oxidase | Homo sapiens (human) | 5 | |
| Glycogen debranching enzyme | Homo sapiens (human) | 10 | |
| Lysosomal alpha-glucosidase | Mus musculus (house mouse) | 9 | |
| Non-lysosomal glucosylceramidase | Mus musculus (house mouse) | 0.14 | |
| Lysosomal alpha-glucosidase | Rattus norvegicus (Norway rat) | 3.7 | |
| Non-lysosomal glucosylceramidase | Homo sapiens (human) | 0.2057 | |
| Putative alpha-glucosidase | Oryza sativa Japonica Group (Japanese rice) | 0.42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for fosamprenavir and miglustat
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |